APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccines

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Selected research

Market Analysis & Forecast

Global Vaccines Market Analysis and Forecast 2026-2032

1 January 2026191 pages

Choose your research edition.

Industry ResearchVaccines Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.

This report presents an overview of global market for Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vaccines sales, projected growth trends, production technology, application and end-user industry.

Vaccines Segment by Company

GSK

Sanofi

Merck

Pfizer

Novartis(GSK)

CSL

MedImmune LLC

J&J(Crucell)

China National Biotec

Tiantan

Hualan

Kangtai

Hissen

Jintan

Vaccines Segment by Type

Recombinant Vaccines

Viral Vaccines

Polysaccharide Vaccines

Others

Vaccines Segment by Application

Rabies vaccine

Influenza vaccine

HPV vaccine

Hepatitis B

Hepatitis A

Leprosy vaccine

Polio vaccine

JE vaccine

Others

Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant Vaccines Major Manufacturers Table 3. Viral Vaccines Major Manufacturers Table 4. Polysaccharide Vaccines Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Rabies vaccine Major Manufacturers Table 8. Influenza vaccine Major Manufacturers Table 9. HPV vaccine Major Manufacturers Table 10. Hepatitis B Major Manufacturers Table 11. Hepatitis A Major Manufacturers Table 12. Leprosy vaccine Major Manufacturers Table 13. Polio vaccine Major Manufacturers Table 14. JE vaccine Major Manufacturers Table 15. Others Major Manufacturers Table 16. Vaccines Industry Trends Table 17. Vaccines Industry Drivers Table 18. Vaccines Industry Opportunities and Challenges Table 19. Vaccines Industry Restraints Table 20. Global Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 22. Global Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 23. Global Vaccines Revenue Market Share by Region (2021-2026) Table 24. Global Vaccines Revenue Market Share by Region (2027-2032) Table 25. Global Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 26. Global Vaccines Sales by Region (2021-2026) & (K Pcs) Table 27. Global Vaccines Sales by Region (2027-2032) & (K Pcs) Table 28. Global Vaccines Sales Market Share by Region (2021-2026) Table 29. Global Vaccines Sales Market Share by Region (2027-2032) Table 30. Global Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 32. Global Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 33. Global Vaccines Sales Market Share by Manufacturers (2021-2026) Table 34. Global Vaccines Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 35. Global Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 36. Global Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 37. Global Vaccines Manufacturers, Product Type & Application Table 38. Global Vaccines Manufacturers' Establishment Date Table 39. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 40. Global Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 43. Global Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 44. Global Vaccines Revenue Market Share by Type (2021-2026) Table 45. Global Vaccines Revenue Market Share by Type (2027-2032) Table 46. Global Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 47. Global Vaccines Sales by Type (2021-2026) & (K Pcs) Table 48. Global Vaccines Sales by Type (2027-2032) & (K Pcs) Table 49. Global Vaccines Sales Market Share by Type (2021-2026) Table 50. Global Vaccines Sales Market Share by Type (2027-2032) Table 51. Global Vaccines Price by Type (2021-2026) & (US$/Pcs) Table 52. Global Vaccines Price by Type (2027-2032) & (US$/Pcs) Table 53. Global Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 55. Global Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 56. Global Vaccines Revenue Market Share by Application (2021-2026) Table 57. Global Vaccines Revenue Market Share by Application (2027-2032) Table 58. Global Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 59. Global Vaccines Sales by Application (2021-2026) & (K Pcs) Table 60. Global Vaccines Sales by Application (2027-2032) & (K Pcs) Table 61. Global Vaccines Sales Market Share by Application (2021-2026) Table 62. Global Vaccines Sales Market Share by Application (2027-2032) Table 63. Global Vaccines Price by Application (2021-2026) & (US$/Pcs) Table 64. Global Vaccines Price by Application (2027-2032) & (US$/Pcs) Table 65. GSK Company Information Table 66. GSK Business Overview Table 67. GSK Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 68. GSK Vaccines Product Portfolio Table 69. GSK Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 73. Sanofi Vaccines Product Portfolio Table 74. Sanofi Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 78. Merck Vaccines Product Portfolio Table 79. Merck Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 83. Pfizer Vaccines Product Portfolio Table 84. Pfizer Recent Development Table 85. Novartis(GSK) Company Information Table 86. Novartis(GSK) Business Overview Table 87. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 88. Novartis(GSK) Vaccines Product Portfolio Table 89. Novartis(GSK) Recent Development Table 90. CSL Company Information Table 91. CSL Business Overview Table 92. CSL Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 93. CSL Vaccines Product Portfolio Table 94. CSL Recent Development Table 95. MedImmune LLC Company Information Table 96. MedImmune LLC Business Overview Table 97. MedImmune LLC Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 98. MedImmune LLC Vaccines Product Portfolio Table 99. MedImmune LLC Recent Development Table 100. J&J(Crucell) Company Information Table 101. J&J(Crucell) Business Overview Table 102. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 103. J&J(Crucell) Vaccines Product Portfolio Table 104. J&J(Crucell) Recent Development Table 105. China National Biotec Company Information Table 106. China National Biotec Business Overview Table 107. China National Biotec Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 108. China National Biotec Vaccines Product Portfolio Table 109. China National Biotec Recent Development Table 110. Tiantan Company Information Table 111. Tiantan Business Overview Table 112. Tiantan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 113. Tiantan Vaccines Product Portfolio Table 114. Tiantan Recent Development Table 115. Hualan Company Information Table 116. Hualan Business Overview Table 117. Hualan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 118. Hualan Vaccines Product Portfolio Table 119. Hualan Recent Development Table 120. Kangtai Company Information Table 121. Kangtai Business Overview Table 122. Kangtai Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 123. Kangtai Vaccines Product Portfolio Table 124. Kangtai Recent Development Table 125. Hissen Company Information Table 126. Hissen Business Overview Table 127. Hissen Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 128. Hissen Vaccines Product Portfolio Table 129. Hissen Recent Development Table 130. Jintan Company Information Table 131. Jintan Business Overview Table 132. Jintan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 133. Jintan Vaccines Product Portfolio Table 134. Jintan Recent Development Table 135. North America Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Vaccines Sales by Type (2021-2026) & (K Pcs) Table 138. North America Vaccines Sales by Type (2027-2032) & (K Pcs) Table 139. North America Vaccines Sales Price by Type (2021-2026) & (US$/Pcs) Table 140. North America Vaccines Sales Price by Type (2027-2032) & (US$/Pcs) Table 141. North America Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Vaccines Sales by Application (2021-2026) & (K Pcs) Table 144. North America Vaccines Sales by Application (2027-2032) & (K Pcs) Table 145. North America Vaccines Sales Price by Application (2021-2026) & (US$/Pcs) Table 146. North America Vaccines Sales Price by Application (2027-2032) & (US$/Pcs) Table 147. North America Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 151. North America Vaccines Sales by Country (2021-2026) & (K Pcs) Table 152. North America Vaccines Sales by Country (2027-2032) & (K Pcs) Table 153. North America Vaccines Sales Price by Country (2021-2026) & (US$/Pcs) Table 154. North America Vaccines Sales Price by Country (2027-2032) & (US$/Pcs) Table 155. United States Vaccines Revenue (2021-2032) & (US$ Million) Table 156. Canada Vaccines Revenue (2021-2032) & (US$ Million) Table 157. Mexico Vaccines Revenue (2021-2032) & (US$ Million) Table 158. Europe Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Vaccines Sales by Type (2021-2026) & (K Pcs) Table 161. Europe Vaccines Sales by Type (2027-2032) & (K Pcs) Table 162. Europe Vaccines Sales Price by Type (2021-2026) & (US$/Pcs) Table 163. Europe Vaccines Sales Price by Type (2027-2032) & (US$/Pcs) Table 164. Europe Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 165. Europe Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 166. Europe Vaccines Sales by Application (2021-2026) & (K Pcs) Table 167. Europe Vaccines Sales by Application (2027-2032) & (K Pcs) Table 168. Europe Vaccines Sales Price by Application (2021-2026) & (US$/Pcs) Table 169. Europe Vaccines Sales Price by Application (2027-2032) & (US$/Pcs) Table 170. Europe Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Europe Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Europe Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Europe Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 174. Europe Vaccines Sales by Country (2021-2026) & (K Pcs) Table 175. Europe Vaccines Sales by Country (2027-2032) & (K Pcs) Table 176. Europe Vaccines Sales Price by Country (2021-2026) & (US$/Pcs) Table 177. Europe Vaccines Sales Price by Country (2027-2032) & (US$/Pcs) Table 178. Germany Vaccines Revenue (2021-2032) & (US$ Million) Table 179. France Vaccines Revenue (2021-2032) & (US$ Million) Table 180. U.K. Vaccines Revenue (2021-2032) & (US$ Million) Table 181. Italy Vaccines Revenue (2021-2032) & (US$ Million) Table 182. Russia Vaccines Revenue (2021-2032) & (US$ Million) Table 183. Spain Vaccines Revenue (2021-2032) & (US$ Million) Table 184. Netherlands Vaccines Revenue (2021-2032) & (US$ Million) Table 185. Switzerland Vaccines Revenue (2021-2032) & (US$ Million) Table 186. Sweden Vaccines Revenue (2021-2032) & (US$ Million) Table 187. Poland Vaccines Revenue (2021-2032) & (US$ Million) Table 188. China Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 189. China Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 190. China Vaccines Sales by Type (2021-2026) & (K Pcs) Table 191. China Vaccines Sales by Type (2027-2032) & (K Pcs) Table 192. China Vaccines Sales Price by Type (2021-2026) & (US$/Pcs) Table 193. China Vaccines Sales Price by Type (2027-2032) & (US$/Pcs) Table 194. China Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 195. China Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 196. China Vaccines Sales by Application (2021-2026) & (K Pcs) Table 197. China Vaccines Sales by Application (2027-2032) & (K Pcs) Table 198. China Vaccines Sales Price by Application (2021-2026) & (US$/Pcs) Table 199. China Vaccines Sales Price by Application (2027-2032) & (US$/Pcs) Table 200. Asia Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 201. Asia Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 202. Asia Vaccines Sales by Type (2021-2026) & (K Pcs) Table 203. Asia Vaccines Sales by Type (2027-2032) & (K Pcs) Table 204. Asia Vaccines Sales Price by Type (2021-2026) & (US$/Pcs) Table 205. Asia Vaccines Sales Price by Type (2027-2032) & (US$/Pcs) Table 206. Asia Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 207. Asia Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 208. Asia Vaccines Sales by Application (2021-2026) & (K Pcs) Table 209. Asia Vaccines Sales by Application (2027-2032) & (K Pcs) Table 210. Asia Vaccines Sales Price by Application (2021-2026) & (US$/Pcs) Table 211. Asia Vaccines Sales Price by Application (2027-2032) & (US$/Pcs) Table 212. Asia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Asia Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Asia Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Asia Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 216. Asia Vaccines Sales by Country (2021-2026) & (K Pcs) Table 217. Asia Vaccines Sales by Country (2027-2032) & (K Pcs) Table 218. Asia Vaccines Sales Price by Country (2021-2026) & (US$/Pcs) Table 219. Asia Vaccines Sales Price by Country (2027-2032) & (US$/Pcs) Table 220. Japan Vaccines Revenue (2021-2032) & (US$ Million) Table 221. South Korea Vaccines Revenue (2021-2032) & (US$ Million) Table 222. India Vaccines Revenue (2021-2032) & (US$ Million) Table 223. Australia Vaccines Revenue (2021-2032) & (US$ Million) Table 224. Taiwan Vaccines Revenue (2021-2032) & (US$ Million) Table 225. Southeast Asia Vaccines Revenue (2021-2032) & (US$ Million) Table 226. SAMEA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 227. SAMEA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 228. SAMEA Vaccines Sales by Type (2021-2026) & (K Pcs) Table 229. SAMEA Vaccines Sales by Type (2027-2032) & (K Pcs) Table 230. SAMEA Vaccines Sales Price by Type (2021-2026) & (US$/Pcs) Table 231. SAMEA Vaccines Sales Price by Type (2027-2032) & (US$/Pcs) Table 232. SAMEA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 233. SAMEA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 234. SAMEA Vaccines Sales by Application (2021-2026) & (K Pcs) Table 235. SAMEA Vaccines Sales by Application (2027-2032) & (K Pcs) Table 236. SAMEA Vaccines Sales Price by Application (2021-2026) & (US$/Pcs) Table 237. SAMEA Vaccines Sales Price by Application (2027-2032) & (US$/Pcs) Table 238. SAMEA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. SAMEA Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. SAMEA Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. SAMEA Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 242. SAMEA Vaccines Sales by Country (2021-2026) & (K Pcs) Table 243. SAMEA Vaccines Sales by Country (2027-2032) & (K Pcs) Table 244. SAMEA Vaccines Sales Price by Country (2021-2026) & (US$/Pcs) Table 245. SAMEA Vaccines Sales Price by Country (2027-2032) & (US$/Pcs) Table 246. Brazil Vaccines Revenue (2021-2032) & (US$ Million) Table 247. Argentina Vaccines Revenue (2021-2032) & (US$ Million) Table 248. Chile Vaccines Revenue (2021-2032) & (US$ Million) Table 249. Colombia Vaccines Revenue (2021-2032) & (US$ Million) Table 250. Peru Vaccines Revenue (2021-2032) & (US$ Million) Table 251. Saudi Arabia Vaccines Revenue (2021-2032) & (US$ Million) Table 252. Israel Vaccines Revenue (2021-2032) & (US$ Million) Table 253. UAE Vaccines Revenue (2021-2032) & (US$ Million) Table 254. Turkey Vaccines Revenue (2021-2032) & (US$ Million) Table 255. Iran Vaccines Revenue (2021-2032) & (US$ Million) Table 256. Egypt Vaccines Revenue (2021-2032) & (US$ Million) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Vaccines Distributors List Table 260. Vaccines Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Vaccines Image Figure 2. Global Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant Vaccines Image Figure 5. Viral Vaccines Image Figure 6. Polysaccharide Vaccines Image Figure 7. Others Image Figure 8. Global Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 10. Rabies vaccine Image Figure 11. Influenza vaccine Image Figure 12. HPV vaccine Image Figure 13. Hepatitis B Image Figure 14. Hepatitis A Image Figure 15. Leprosy vaccine Image Figure 16. Polio vaccine Image Figure 17. JE vaccine Image Figure 18. Others Image Figure 19. Global Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Vaccines Revenue (2021-2032) & (US$ Million) Figure 21. Global Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 23. Global Vaccines Revenue Market Share by Region (2021-2032) Figure 24. Global Vaccines Sales (2021-2032) & (K Pcs) Figure 25. Global Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 26. Global Vaccines Sales Market Share by Region (2021-2032) Figure 27. US & Canada & Mexico Vaccines Sales YoY (2021-2032) & (K Pcs) Figure 28. Europe Vaccines Sales YoY (2021-2032) & (K Pcs) Figure 29. China Vaccines Sales YoY (2021-2032) & (K Pcs) Figure 30. Asia (Excluding China) Vaccines Sales YoY (2021-2032) & (K Pcs) Figure 31. South America, Middle East and Africa Vaccines Sales YoY (2021-2032) & (K Pcs) Figure 32. Global Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 33. Global Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 34. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Global Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Vaccines Revenue Market Share by Type (2021-2032) Figure 38. Global Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 39. Global Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 40. Global Vaccines Sales Market Share by Type (2021-2032) Figure 41. Global Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 42. Global Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Vaccines Revenue Market Share by Application (2021-2032) Figure 44. Global Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 45. Global Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 46. Global Vaccines Sales Market Share by Application (2021-2032) Figure 47. North America Vaccines Revenue Share by Type (2021-2032) Figure 48. North America Vaccines Sales Share by Type (2021-2032) Figure 49. North America Vaccines Revenue Share by Application (2021-2032) Figure 50. North America Vaccines Sales Share by Application (2021-2032) Figure 51. North America Vaccines Revenue Share by Country (2021-2032) Figure 52. North America Vaccines Sales Share by Country (2021-2032) Figure 53. Europe Vaccines Revenue Share by Type (2021-2032) Figure 54. Europe Vaccines Sales Share by Type (2021-2032) Figure 55. Europe Vaccines Revenue Share by Application (2021-2032) Figure 56. Europe Vaccines Sales Share by Application (2021-2032) Figure 57. Europe Vaccines Revenue Share by Country (2021-2032) Figure 58. Europe Vaccines Sales Share by Country (2021-2032) Figure 59. China Vaccines Revenue Share by Type (2021-2032) Figure 60. China Vaccines Sales Share by Type (2021-2032) Figure 61. China Vaccines Revenue Share by Application (2021-2032) Figure 62. China Vaccines Sales Share by Application (2021-2032) Figure 63. Asia Vaccines Revenue Share by Type (2021-2032) Figure 64. Asia Vaccines Sales Share by Type (2021-2032) Figure 65. Asia Vaccines Revenue Share by Application (2021-2032) Figure 66. Asia Vaccines Sales Share by Application (2021-2032) Figure 67. Asia Vaccines Revenue Share by Country (2021-2032) Figure 68. Asia Vaccines Sales Share by Country (2021-2032) Figure 69. SAMEA Vaccines Revenue Share by Type (2021-2032) Figure 70. SAMEA Vaccines Sales Share by Type (2021-2032) Figure 71. SAMEA Vaccines Revenue Share by Application (2021-2032) Figure 72. SAMEA Vaccines Sales Share by Application (2021-2032) Figure 73. SAMEA Vaccines Revenue Share by Country (2021-2032) Figure 74. SAMEA Vaccines Sales Share by Country (2021-2032) Figure 75. Vaccines Value Chain Figure 76. Manufacturing Cost Structure Figure 77. Vaccines Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Years Considered Figure 81. Research Process Figure 82. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Viral Vaccines
  • Polysaccharide Vaccines
  • Others
Applications
  • Rabies vaccine
  • Influenza vaccine
  • HPV vaccine
  • Hepatitis B
  • Hepatitis A
  • Leprosy vaccine
  • Polio vaccine
  • JE vaccine
  • Others
Companies covered
  • GSK
  • Sanofi
  • Merck
  • Pfizer
  • Novartis(GSK)
  • CSL
  • MedImmune LLC
  • J&J(Crucell)
  • China National Biotec
  • Tiantan
  • Hualan
  • Kangtai
  • Hissen
  • Jintan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vaccines Market by Type
  3. 1.2.1 Global Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant Vaccines
  5. 1.2.3 Viral Vaccines
  6. 1.2.4 Polysaccharide Vaccines
  7. 1.2.5 Others
  8. 1.3 Vaccines Market by Application
  9. 1.3.1 Global Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Rabies vaccine
  11. 1.3.3 Influenza vaccine
  12. 1.3.4 HPV vaccine
  13. 1.3.5 Hepatitis B
  14. 1.3.6 Hepatitis A
  15. 1.3.7 Leprosy vaccine
  16. 1.3.8 Polio vaccine
  17. 1.3.9 JE vaccine
  18. 1.3.10 Others
  19. 1.4 Assumptions and Limitations
  20. 1.5 Study Goals and Objectives
2 Vaccines Market Dynamics
  1. 2.1 Vaccines Industry Trends
  2. 2.2 Vaccines Industry Drivers
  3. 2.3 Vaccines Industry Opportunities and Challenges
  4. 2.4 Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vaccines Revenue by Region
  3. 3.2.1 Global Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vaccines Sales by Region
  9. 3.4.1 Global Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vaccines Sales by Manufacturers
  6. 4.2.1 Global Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Vaccines Tier 1, Tier 2, and Tier 3
5 Vaccines Market by Type
  1. 5.1 Global Vaccines Revenue by Type
  2. 5.1.1 Global Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vaccines Sales by Type
  6. 5.2.1 Global Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vaccines Sales by Type (2021-2032) & (K Pcs)
  8. 5.2.3 Global Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vaccines Price by Type
6 Vaccines Market by Application
  1. 6.1 Global Vaccines Revenue by Application
  2. 6.1.1 Global Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vaccines Sales by Application
  6. 6.2.1 Global Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vaccines Sales by Application (2021-2032) & (K Pcs)
  8. 6.2.3 Global Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vaccines Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Vaccines Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Vaccines Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Vaccines Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Vaccines Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Novartis(GSK)
  26. 7.5.1 Novartis(GSK) Company Information
  27. 7.5.2 Novartis(GSK) Business Overview
  28. 7.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis(GSK) Vaccines Product Portfolio
  30. 7.5.5 Novartis(GSK) Recent Developments
  31. 7.6 CSL
  32. 7.6.1 CSL Company Information
  33. 7.6.2 CSL Business Overview
  34. 7.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 CSL Vaccines Product Portfolio
  36. 7.6.5 CSL Recent Developments
  37. 7.7 MedImmune LLC
  38. 7.7.1 MedImmune LLC Company Information
  39. 7.7.2 MedImmune LLC Business Overview
  40. 7.7.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MedImmune LLC Vaccines Product Portfolio
  42. 7.7.5 MedImmune LLC Recent Developments
  43. 7.8 J&J(Crucell)
  44. 7.8.1 J&J(Crucell) Company Information
  45. 7.8.2 J&J(Crucell) Business Overview
  46. 7.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 J&J(Crucell) Vaccines Product Portfolio
  48. 7.8.5 J&J(Crucell) Recent Developments
  49. 7.9 China National Biotec
  50. 7.9.1 China National Biotec Company Information
  51. 7.9.2 China National Biotec Business Overview
  52. 7.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 China National Biotec Vaccines Product Portfolio
  54. 7.9.5 China National Biotec Recent Developments
  55. 7.10 Tiantan
  56. 7.10.1 Tiantan Company Information
  57. 7.10.2 Tiantan Business Overview
  58. 7.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Tiantan Vaccines Product Portfolio
  60. 7.10.5 Tiantan Recent Developments
  61. 7.11 Hualan
  62. 7.11.1 Hualan Company Information
  63. 7.11.2 Hualan Business Overview
  64. 7.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hualan Vaccines Product Portfolio
  66. 7.11.5 Hualan Recent Developments
  67. 7.12 Kangtai
  68. 7.12.1 Kangtai Company Information
  69. 7.12.2 Kangtai Business Overview
  70. 7.12.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Kangtai Vaccines Product Portfolio
  72. 7.12.5 Kangtai Recent Developments
  73. 7.13 Hissen
  74. 7.13.1 Hissen Company Information
  75. 7.13.2 Hissen Business Overview
  76. 7.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hissen Vaccines Product Portfolio
  78. 7.13.5 Hissen Recent Developments
  79. 7.14 Jintan
  80. 7.14.1 Jintan Company Information
  81. 7.14.2 Jintan Business Overview
  82. 7.14.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Jintan Vaccines Product Portfolio
  84. 7.14.5 Jintan Recent Developments
8 North America
  1. 8.1 North America Vaccines Market Size by Type
  2. 8.1.1 North America Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Vaccines Price by Type (2021-2032)
  5. 8.2 North America Vaccines Market Size by Application
  6. 8.2.1 North America Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Vaccines Price by Application (2021-2032)
  9. 8.3 North America Vaccines Market Size by Country
  10. 8.3.1 North America Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Vaccines Market Size by Type
  2. 9.1.1 Europe Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Vaccines Market Size by Application
  6. 9.2.1 Europe Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Vaccines Market Size by Country
  10. 9.3.1 Europe Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Vaccines Market Size by Type
  2. 10.1.1 China Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Vaccines Price by Type (2021-2032)
  5. 10.2 China Vaccines Market Size by Application
  6. 10.2.1 China Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vaccines Market Size by Type
  2. 11.1.1 Asia Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Vaccines Market Size by Application
  6. 11.2.1 Asia Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Vaccines Market Size by Country
  10. 11.3.1 Asia Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vaccines Market Size by Type
  2. 12.1.1 SAMEA Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Vaccines Market Size by Application
  6. 12.2.1 SAMEA Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Vaccines Market Size by Country
  10. 12.3.1 SAMEA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vaccines Value Chain Analysis
  2. 13.1.1 Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vaccines Production Mode & Process
  6. 13.2 Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vaccines Distributors
  9. 13.2.3 Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst